Hangzhou Tigermed Consulting (03347) clarifies: The two actual controllers have each conducted corresponding announcements for each reduction of shares.

Hangzhou Tigermed Consulting (03347) announced that its director and controlling shareholder, Mr. Ye Xiaoping and Ms. Cao Xiaochun, have received a notice of filing from the China Securities Regulatory Commission. The company has noticed speculation in the market regarding whether Mr. Ye and Ms. Cao have made the required public announcements and disclosures. After conducting a reasonable inquiry into the relevant circumstances concerning the company, Hangzhou Tigermed Consulting hereby clarifies and emphasizes that the investigation relates to disclosure matters regarding the shareholding changes of Mr. Ye and Ms. Cao in the past. Both actual controlling shareholders have made announcements for each reduction of their holdings, and the shareholding situation has also been disclosed in the company's regular reports. The information disclosure obligations have been fulfilled with the submission of the "Abriged Equities Change Report." These matters are unrelated to the company's business operations and will not impact its normal business operations.